Two drugs converged in a pancreatic β cell.

Published in: Science translational medicine (2020)

Combining a DYRK1A inhibitor and GLP-1 receptor agonist boosts human pancreatic β cell proliferation and glucose homeostasis in vivo (Ackeifi et al., this issue).

Keyphrases

cell proliferation
endothelial cells
single cell
cell therapy
induced pluripotent stem cells
cell cycle
pluripotent stem cells
blood glucose
pi k akt
blood pressure
stem cells
weight loss